These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 2509108

  • 21. Outcome of cadaveric renal transplantation by induction treatment in the cyclosporine era.
    Hariharan S, Alexander JW, Schroeder TJ, First MR.
    Clin Transplant; 1996 Apr; 10(2):186-90. PubMed ID: 8664516
    [Abstract] [Full Text] [Related]

  • 22. A prospective randomized controlled trial of initial immunosuppression with ALG versus OKT3 in recipients of cardiac allografts.
    Menkis AH, Powell AM, Novick RJ, McKenzie FN, Kostuk WJ, Pflugfelder PW, Brown JE, Rochon J, Chow LH, Stiller C.
    J Heart Lung Transplant; 1992 Apr; 11(3 Pt 1):569-76. PubMed ID: 1610866
    [Abstract] [Full Text] [Related]

  • 23. Immunosuppressive efficacy of vincristine in heart transplantation: a preliminary report.
    Gilbert EM, Renlund DG, O'Connell JB, Eiswirth CC, Rothstein G, Gay WA, Bristow MR.
    J Heart Transplant; 1987 Apr; 6(6):369-74. PubMed ID: 3320307
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. A prospective randomized study of prophylactic OKT3 versus equine antithymocyte globulin after heart transplantation--increased morbidity with OKT3.
    Macdonald PS, Mundy J, Keogh AM, Chang VP, Spratt PM.
    Transplantation; 1993 Jan; 55(1):110-6. PubMed ID: 8380508
    [Abstract] [Full Text] [Related]

  • 27. OKT3 prophylaxis versus conventional drug therapy: single-center perspective, part of a multicenter trial.
    Kahana L, Narvarte J, Ackermann J, LeFor W, Weinstein S, Wright C, deQuesada A, Baxter J, Shires D.
    Am J Kidney Dis; 1989 Nov; 14(5 Suppl 2):5-9. PubMed ID: 2510510
    [Abstract] [Full Text] [Related]

  • 28. Treatment of steroid-resistant and recurrent acute cardiac transplant rejection with a short course of antibody therapy.
    Cantarovich M, Latter DA, Loertscher R.
    Clin Transplant; 1997 Aug; 11(4):316-21. PubMed ID: 9267721
    [Abstract] [Full Text] [Related]

  • 29. HLA-DR incompatibility predicts heart transplant rejection independent of immunosuppressive prophylaxis.
    Costanzo-Nordin MR, Fisher SG, O'Sullivan EJ, Johnson M, Heroux A, Kao W, Mullen GM, Radvany R, Robinson J.
    J Heart Lung Transplant; 1993 Aug; 12(5):779-89. PubMed ID: 8241215
    [Abstract] [Full Text] [Related]

  • 30. To induce or not to induce: do patients at greatest risk for fatal rejection benefit from cytolytic induction therapy?
    Higgins R, Kirklin JK, Brown RN, Rayburn BK, Wagoner L, Oren R, Miller L, Flattery M, Bourge RC, Cardiac Transplant Research Database (CTRD).
    J Heart Lung Transplant; 2005 Apr; 24(4):392-400. PubMed ID: 15797738
    [Abstract] [Full Text] [Related]

  • 31. Induction therapy with cyclosporine without cytolytic agents results in a low incidence of acute rejection without significant renal impairment in heart transplant patients.
    Jazzar A, Fagiuoli S, Sisson S, Zuhdi N, Cooper DK.
    Clin Transplant; 1995 Aug; 9(4):334-9. PubMed ID: 7579743
    [Abstract] [Full Text] [Related]

  • 32. [Kidney-pancreas transplantation. Clinical results in 23 consecutive patients].
    Maestri M, Krieger N, Kuo P, Dafoe DC, Alfrey EJ.
    Minerva Chir; 1998 Mar; 53(3):121-8. PubMed ID: 9617106
    [Abstract] [Full Text] [Related]

  • 33. Efficacy of low-dose OKT3 as cytolytic induction therapy in heart transplantation.
    Alonso-Pulpón L, Serrano-Fiz S, Rubio JA, Cavero MA, Silva L, Sánchez-Vegazo I, Burgos R, Montero CG, Maicas C, Kreisler M.
    J Heart Lung Transplant; 1995 Mar; 14(1 Pt 1):136-42. PubMed ID: 7727462
    [Abstract] [Full Text] [Related]

  • 34. Comparison of Minnesota antilymphocyte globulin and OKT3 for induction of immunosuppression in renal transplant patients.
    Light JA, Khawand N, Ali A, Brems W, Aquino A.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1738-40. PubMed ID: 2652569
    [Abstract] [Full Text] [Related]

  • 35. A randomized prospective trial of prophylactic immunosuppression with ATG-fresenius versus OKT3 after renal transplantation.
    Bock HA, Gallati H, Zürcher RM, Bachofen M, Mihatsch MJ, Landmann J, Thiel G.
    Transplantation; 1995 Mar 27; 59(6):830-40. PubMed ID: 7701577
    [Abstract] [Full Text] [Related]

  • 36. Methotrexate or total lymphoid radiation for treatment of persistent or recurrent allograft cellular rejection: a comparative study.
    Ross HJ, Gullestad L, Pak J, Slauson S, Valantine HA, Hunt SA.
    J Heart Lung Transplant; 1997 Feb 27; 16(2):179-89. PubMed ID: 9059929
    [Abstract] [Full Text] [Related]

  • 37. Antilymphocyte induction immunosuppression in the post-Minnesota anti-lymphocyte globulin era: incidence of renal dysfunction and delayed graft function. A single center experience.
    Malinow L, Walker J, Klassen D, Oldach D, Schweitzer E, Bartlett ST, Weir MR.
    Clin Transplant; 1996 Jun 27; 10(3):237-42. PubMed ID: 8826659
    [Abstract] [Full Text] [Related]

  • 38. Induction therapy after cardiac transplantation: a comparison of anti-thymocyte globulin and daclizumab in the prevention of acute rejection.
    Carlsen J, Johansen M, Boesgaard S, Andersen CB, Arendrup H, Aldershvilet J, Mortensen SA.
    J Heart Lung Transplant; 2005 Mar 27; 24(3):296-302. PubMed ID: 15737756
    [Abstract] [Full Text] [Related]

  • 39. Renal transplantation at the Washington Hospital Center: experience with OKT3 and Minnesota antilymphoblast globulin for induction of immunosuppression.
    Jonsson J, Light JA, Korb SM.
    Clin Transpl; 1990 Mar 27; ():275-88. PubMed ID: 2129409
    [Abstract] [Full Text] [Related]

  • 40. Independent risk factors predicting acute graft rejection in cardiac transplant recipients treated by triple drug immunosuppression.
    Laufer G, Miholic J, Laczkovics A, Wollenek G, Holzinger C, Hajek-Rosenmeier A, Wuzl G, Schreiner W, Buxbaum P, Wolner E.
    J Thorac Cardiovasc Surg; 1989 Dec 27; 98(6):1113-21. PubMed ID: 2586129
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.